Latest Regulatory Scrutiny News

Macquarie Group Limited has posted a 5% increase in net profit for FY2025, driven by strong asset management and banking growth, while advancing its sustainability and digital innovation agenda.

AF Legal Group has resolved a significant legal claim related to a senior lawyer's 2022 hire, incurring up to $600,000 in costs, while navigating an ongoing regulatory probe. Despite these challenges, the firm remains optimistic about improved profitability in the second half of FY25.

ANZ Group Holdings Limited delivered its strongest half-year revenue and profit to date, buoyed by the full contribution from Suncorp Bank and a robust capital position despite regulatory challenges.

Tivan Limited has responded to ASX inquiries about a social media post by its executive chair concerning fluorite exploration, affirming compliance with disclosure rules and pending assay results.

National Australia Bank has reported robust half-year results with cash earnings of $3.58 billion and announced a fully franked interim dividend of 85 cents per share, underscoring its strong market position and strategic clarity.

Pancontinental Energy has responded to an ASX query about recent spikes in its share price and trading volume, confirming no undisclosed information exists and pointing to strong industry interest in its PEL 87 project.

Citigold Corporation Limited has faced intense ASX scrutiny following an adverse auditor opinion on its half-year financials, centering on a $20 million impairment of exploration assets. The company defends its valuation approach despite funding uncertainties and regulatory questions.

PointsBet Holdings has received a confidential acquisition proposal from Betr Entertainment, prompting a careful evaluation by its Board while reaffirming support for the existing MIXI Scheme.

Reef Casino Trust’s responsible entity confirms ongoing confidential negotiations with two parties over potential acquisition proposals exceeding A$200 million, though no deal is assured.

Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.

Global Lithium Resources has resumed its Definitive Feasibility Study at the Manna Lithium Project, focusing on cost optimization and project economics, while advancing heritage and native title agreements. The company also reported significant board changes and a robust cash position heading into 2025.

PEXA has achieved a crucial regulatory milestone with FCA approval to operate as an Authorised Payment Institution in the UK, paving the way for its Sale & Purchase product launch later this year.